Our identification of CoQ10 and its more soluble analog idebenone as partial agonists for both PPARα and PPARγ provides new insight into PPAR molecular and genetic functions, as well as promising new reagents for treating and preventing metabolic disorders. The gene discussed is PPARG; the disease is Other metabolic disease.